US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
NeuroSense Therapeutics Ltd (NRSNW)
NeuroSense Therapeutics Ltd (NRSNW) ニュース

NRSNW

NeuroSense Therapeutics (NRSNW)

NeuroSense Therapeutics Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NRSNW

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/28	20 : 14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/24	05 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/23	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/23	06 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/21	05 : 16	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/20	22 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/14	22 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/11	05 : 15	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd
2024/05/07	23 : 21	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NRSNW	NeuroSense Therapeutics Ltd

Showing the most relevant articles for your search:NASDAQ:NRSNW

1

Canadian Utilities

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約